Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation

Background: Atrial fibrillation (AF) with fast ventricular response over an overt accessory pathway (AP) (preexcited AF) with a short anterograde refractory period is a potentially malignant arrhythmia. This study aimed to evaluate the safety and efficacy of amiodarone for preexcited AF management....

Full description

Bibliographic Details
Main Authors: Abolfath Alizadeh, Maryam Pakroo, Shabnam Madadi, Ala Keikhavani, Zahra Teimouri-Jervekani, Behshid Ghadrdoost, Zahra Emkanjoo
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Journal of Research in Medical Sciences
Subjects:
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2022;volume=27;issue=1;spage=69;epage=69;aulast=Alizadeh
_version_ 1811343198788780032
author Abolfath Alizadeh
Maryam Pakroo
Shabnam Madadi
Ala Keikhavani
Zahra Teimouri-Jervekani
Behshid Ghadrdoost
Zahra Emkanjoo
author_facet Abolfath Alizadeh
Maryam Pakroo
Shabnam Madadi
Ala Keikhavani
Zahra Teimouri-Jervekani
Behshid Ghadrdoost
Zahra Emkanjoo
author_sort Abolfath Alizadeh
collection DOAJ
description Background: Atrial fibrillation (AF) with fast ventricular response over an overt accessory pathway (AP) (preexcited AF) with a short anterograde refractory period is a potentially malignant arrhythmia. This study aimed to evaluate the safety and efficacy of amiodarone for preexcited AF management. Materials and Methods: This study enrolled 103 patients with evidence of AP in electrocardiography. Patients with preexcited AF were included in the study. Intravenous amiodarone (300 mg) was infused for 30 min for all patients in the AF rhythm. Electrophysiological parameters were evaluated before amiodarone injection and 2 h after pharmacological or electrical cardioversion. Results: Antegrade and retrograde refractory periods of the atrioventricular node (AVN) and AP, as well as antegrade and retrograde Wenckebach points of AVN, were increased significantly after amiodarone infusion. Furthermore, the mean of the shortest preexcited RR interval was increased during the monitoring period. Comparing the preexcited index at the beginning of the study and before cardioversion (2 h later) revealed that the QRS complexes changed to a wider pattern as the preexcitation index changed from 80.61 to 92.26 (P < 0.001). Nineteen (18.4%) patients converted to the sinus rhythm with amiodarone infusion. No ventricular arrhythmia was detected during monitoring. Conclusion: Amiodarone could be considered a safe drug in patients with preexcited AF for rate control despite its relatively low efficacy in conversion to the sinus rhythm.
first_indexed 2024-04-13T19:24:20Z
format Article
id doaj.art-32f1dedaae09434a9048a99e5e4e7af7
institution Directory Open Access Journal
issn 1735-1995
1735-7136
language English
last_indexed 2024-04-13T19:24:20Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Research in Medical Sciences
spelling doaj.art-32f1dedaae09434a9048a99e5e4e7af72022-12-22T02:33:24ZengWolters Kluwer Medknow PublicationsJournal of Research in Medical Sciences1735-19951735-71362022-01-01271696910.4103/jrms.jrms_91_22Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillationAbolfath AlizadehMaryam PakrooShabnam MadadiAla KeikhavaniZahra Teimouri-JervekaniBehshid GhadrdoostZahra EmkanjooBackground: Atrial fibrillation (AF) with fast ventricular response over an overt accessory pathway (AP) (preexcited AF) with a short anterograde refractory period is a potentially malignant arrhythmia. This study aimed to evaluate the safety and efficacy of amiodarone for preexcited AF management. Materials and Methods: This study enrolled 103 patients with evidence of AP in electrocardiography. Patients with preexcited AF were included in the study. Intravenous amiodarone (300 mg) was infused for 30 min for all patients in the AF rhythm. Electrophysiological parameters were evaluated before amiodarone injection and 2 h after pharmacological or electrical cardioversion. Results: Antegrade and retrograde refractory periods of the atrioventricular node (AVN) and AP, as well as antegrade and retrograde Wenckebach points of AVN, were increased significantly after amiodarone infusion. Furthermore, the mean of the shortest preexcited RR interval was increased during the monitoring period. Comparing the preexcited index at the beginning of the study and before cardioversion (2 h later) revealed that the QRS complexes changed to a wider pattern as the preexcitation index changed from 80.61 to 92.26 (P < 0.001). Nineteen (18.4%) patients converted to the sinus rhythm with amiodarone infusion. No ventricular arrhythmia was detected during monitoring. Conclusion: Amiodarone could be considered a safe drug in patients with preexcited AF for rate control despite its relatively low efficacy in conversion to the sinus rhythm.http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2022;volume=27;issue=1;spage=69;epage=69;aulast=Alizadehaccessory pathwayamiodaroneatrial fibrillationelectrophysiology
spellingShingle Abolfath Alizadeh
Maryam Pakroo
Shabnam Madadi
Ala Keikhavani
Zahra Teimouri-Jervekani
Behshid Ghadrdoost
Zahra Emkanjoo
Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation
Journal of Research in Medical Sciences
accessory pathway
amiodarone
atrial fibrillation
electrophysiology
title Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation
title_full Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation
title_fullStr Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation
title_full_unstemmed Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation
title_short Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation
title_sort electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation
topic accessory pathway
amiodarone
atrial fibrillation
electrophysiology
url http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2022;volume=27;issue=1;spage=69;epage=69;aulast=Alizadeh
work_keys_str_mv AT abolfathalizadeh electrophysiologicalandtherapeuticeffectsofamiodaroneinpatientswithpreexcitedatrialfibrillation
AT maryampakroo electrophysiologicalandtherapeuticeffectsofamiodaroneinpatientswithpreexcitedatrialfibrillation
AT shabnammadadi electrophysiologicalandtherapeuticeffectsofamiodaroneinpatientswithpreexcitedatrialfibrillation
AT alakeikhavani electrophysiologicalandtherapeuticeffectsofamiodaroneinpatientswithpreexcitedatrialfibrillation
AT zahrateimourijervekani electrophysiologicalandtherapeuticeffectsofamiodaroneinpatientswithpreexcitedatrialfibrillation
AT behshidghadrdoost electrophysiologicalandtherapeuticeffectsofamiodaroneinpatientswithpreexcitedatrialfibrillation
AT zahraemkanjoo electrophysiologicalandtherapeuticeffectsofamiodaroneinpatientswithpreexcitedatrialfibrillation